B lymphocyte autoimmunity in rheumatoid synovitis is independent of ectopic lymphoid neogenesis

Journal of Immunology

Volumn 181, Issue 1, 2008, Pages 785-794

  Cantaert, Tineke ^a   Kolln, Johanna ^a   Timmer, Trieneke ^c   Van Der Pouw Kraan, Tineke C ^c   Vandooren, Bernard ^a,d   Thurlings, Rogier M ^a   Cañete, Juan D ^e   Catrina, Anca I ^f   Out, Theo ^a   Verweij, Cor L ^c   Zhang, Yiping ^b   Tak, Paul P ^a   Baeten, Dominique ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

^e HOSPITAL CLÍNIC   (Spain)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CHEMOKINE; CITRULLINE; CYTOKINE; RHEUMATOID FACTOR; B CELL ACTIVATING FACTOR; TNFRSF13B PROTEIN, HUMAN; TNFSF13B PROTEIN, HUMAN; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR;

ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CYTOKINE RELEASE; GERMINAL CENTER; HUMAN; HUMORAL IMMUNITY; IMMUNOPATHOGENESIS; LYMPH FOLLICLE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SERODIAGNOSIS; STRUCTURE ANALYSIS; SYNOVITIS; ADULT; AGED; AUTOIMMUNITY; B LYMPHOCYTE; CHORISTOMA; CYTOLOGY; DISEASE COURSE; FEMALE; IMMUNOLOGY; LYMPH NODE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOIMMUNITY; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; CELL DIFFERENTIATION; CHEMOKINES; CHORISTOMA; DISEASE PROGRESSION; FEMALE; GERMINAL CENTER; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; SYNOVITIS; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN;

EID: 47949114181     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.1.785     Document Type: Article

References (67)

1. Sebbag, M., M. Simon, C. Vincent, C. Masson-Bessiere, E. Girbal, J. J. Durieux, and G. Serre. 1995. The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J. Clin. Invest. 95: 2672-2679.
2. Kuhn, K. A., L. Kulik, B. Tomooka, K. J. Braschler, W. P. Arend, W. H. Robinson, and V. M. Holers. 2006. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J. Clin. Invest. 116:961-973.
3. Klareskog, L., P. Stolt, K. Lundberg, H. Kallberg, C. Bengtsson, J. Grunewald, J. Ronnelid, H. E. Harris, A. K. Ulfgren, S. Rantapaa-Dahlqvist, et al. 2006. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared cpitope)-restricted immune reactions to autoantigens modified by citrul-Iination. Arthritis Rheum, 54: 38-46.
4. Reparon-Schuijt, C. C., W. J. van Esch, C. van Kooten, G. A. Schellekens, B. A. de Jong, W. J. van Venrooij, F. C. Breedveld, and C. L. Verweij. 2001. Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis. Arthritis Rheum. 44: 41-47.
5. Masson-Bessiere, C., M. Sebbag, J. J. Durieux, L. Nogueira, C. Vincent, E. Girbal-Neuhauser, R. Durroux, A. Cantagrel, and G. Serre. 2000. In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin. Exp. Immunol. 119: 544-552.
6. Iwaki-Egawa, S., H. Matsuno, Y. Ogawa, and Y. Watanabe. 2005. Production of anti-CCP antibodies and matrix metalloproteinase-3 by human rheumatoid arthritis synovial tissues using SCID mice. Annu. Rheum. Dis. 64: 1094-1095.
7. Vossenaar, E., T. J. Smeets, M. C. Kraan, J. M. Raats, W. J. van Venrooij, and P. P. Tak. 2004. The presence of citrullinated proteins is not specific for rheumatoid synovial tissue. Arthritis Rheum. 50: 3485-3494.
8. Chapuy-Regaud, S., M. Sebbag, D. Baeten, C. Clavel, C. Foulquier, F. De Keyser, and G. Serre. 2005. Fibrin deimination in synovial tissue is not specific for rheumatoid arthritis but commonly occurs during synovitides. J. Immunol. 174: 5057-5064.
9. Cantaert, T., L. De Rycke, T. Bongartz, E. L. Matteson, P. P. Tak, A. P. Nicholas, and D. Baeten. 2006. Citrullinated proteins in rheumatoid arthritis: crucial but not sufficient! Arthritis Rheum. 54: 3381-3389.
10. Klimiuk, P. A., J. J. Goronzy, J. Bjomsson, R. D. Beckenbaugh, and C. M. Weyand. 1997. Tissue cytokine patterns distinguish variants of rheumatoid synovitis. Am. J. Pathol. 151: 1311-1319.
11. Kang, Y. M., X. Zhang, U. G. Wagner, H. Yang, R. D. Beckenbaugh, P. J. Kurtin, J. J. Goronzy, and C. M. Weyand. 2002. CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis. J. Exp. Med. 195: 1325-1336.
12. + T cells in the formation of germinal centers in rheumatoid synovitis. J. Immunol. 161: 6390-6397.
13. Weyand, C. M., P. J. Kurtin, and J. J. Goronzy. 2001. Ectopic lymphoid orga-nogenesis: a fast track for autoimmunity. Am. J. Palhol. 159: 787-793.
14. Schroder, A. E., A. Greiner, C. Seyfert, and C. Berek. 1996. Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 93: 221-225.
15. Takemura, S., A. Braun, C. Crowson, P. J. Kurtin, R. H. Cofield, W. M. O'Fallon, J. J. Goronzy, and C. M. Weyand. 2001. Lymphoid neogenesis in rheumatoid synovitis. J. Immunol. 167: 1072-1080.
16. Baeten, D., F. Van den Bosch, D. Elewaut, A. Stuer, E. M. Veys, and F. De Keyser. 1999. Needle arthroscopy of the knee with synovial biopsy sampling: technical experience in 150 patients. Clin. Rheumatol. 18: 434-441.
17. Baeten, D., E. Kruithof, L. De Rycke, B. Vandooren, B. Wyns, L. Boullart, I. E. Hoffman, A. M. Boots, E. M. Veys, and F. De Keyser. 2004. Diagnostic classification of spondylarthropathy and rheumatoid arthritis by synovial histo-pathology: a prospective study in 154 consecutive patients. Arthritis Rheum. 50: 2931-2941.
18. Arnett, F. C., S. M. Edworthy, D. A. Bloch, D. J. McShane, J. F. Fries, N. S. Cooper, L. A. Healey, S. R. Kaplan, M. H. Liang, H. S. Luthra, et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31: 315-324.
19. Dougados, M., S. van der Linden, R. Juhlin, B. Huitfeldt, B. Amor, A. Calin, A. Cats, B. Dijkmans, I. Olivieri, G. Pasero, et al. 1991. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 34: 1218-1227.
20. Kruilhof, E., D. Baeten, F. Van den Bosch, H. Mielants, E. M. Veys, and F. De Keyser. 2005. Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in s'pondyloarlhropathy. Ann. Rheum. Dis. 64: 529-536.
21. Kruithof, E., L. De Rycke, J. Roth, H. Mielants, F. Van den Bosch, F. De Keyser, E. M. Veys, and D. Baeten. 2005. Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies. Arthritis Rheum. 52: 3898-3909.
22. Yanni, G., A. Whelan, C. Feighery, and B. Bresnihan. 1992. Analysis of cell populations in rheumatoid arthritis synovial tissues. Semin. Arthritis Rheum. 21: 393-399.
23. Manzo, A., S. Paoletti, M. Carulli, M. C. Blades, F. Barone, G. Yanni, O. Fitzgerald, B. Bresnihan, R. Caporali, C. Montecucco, et al. 2005. Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis. Eur. J. Immunol. 35: 1347-1359.
24. Drayton, D. L., S. Liao, R. H. Mounzer, and N. H. Ruddle. 2006. Lymphoid organ development: from ontogeny to neogenesis. Nat. Immunol. 7: 344-353.
25. Janeway, C. A., P. Travers, M. Walport, and M. J. Shlomchik. 2005. lmmuno-biology. Garland Science Publishing, New York, pp. 5: 349-356.
26. Canete, J. D., B. Santiago, T. Cantaert, R. Sanmarti, A. Palacin, R. Celis, E. Graell, B. Gil-Torregrosa, D. Baeten, and J. L. Pablos. 2007. Ectopic lymphoid neogenesis in psoriatic arthritis. Ann. Rheum. Dis. 66: 720-726.
27. Kasperkovitz, P. V., T. C. Timmer, T. J. Smeets, N. L. Verbeet, P. P. Tak, L. G. van Baarsen, B. Baltus, T. W. Huizinga, E. Pieterman, M. Fero, et al. 2005. Fibroblast-like synoviocytes derived from patients with rheumatoid arthritis show the imprint of synovial tissue heterogeneity: evidence of a link between an increased myofibroblast-like phenotype and high-inflammation synovitis. Arthritis Rheum. 52:430-441.
28. Da, R. R., Y. Qin, D. Baeten, and Y. Zhang. 2007. B cell clonal expansion and somatic hypermutation of Ig variable heavy chain genes in the synovial membrane of patients with osteoarthritis. J. Immunol. 178: 557-565.
29. Hanahan, D. 1983. Studies on transformation of Escherichia coli with plasmids. J. Mol. Biol. 166: 557-580.
30. Marchal-Somme, J., Y. Uzunhan, S. Marchand-Adam, D. Valeyre, V. Soumelis, B. Crestani, and P. Soler. 2006. Cutting edge: nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis. J. Immunol. 176: 5735-5739.
31. Cantaert, T., P. Coucke, L. De Rycke, E. M. Veys, F. De Keyser, and D. Baeten. 2005. Functional haplotypes of PADI4: relevance for rheumatoid arthritis specific synovial intracellular citrullinated proteins and anticitrullinated protein antibodies. Ann. Rheum. Dis. 64: 1316-1320.
32. De Rycke, L., A. P. Nicholas, T. Cantaert, E. Kruithof, J. D. Echols, B. Vandekerckhove, E. M. Veys, F. De Keyser, and D. Baeten. 2005. Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunily. Arthritis Rheum. 52: 2323-2330.
33. Liu, Y. J., J. Xu, O. de Bouteiller, C. L. Parham, G. Grouard, O. Djossou, B. de Saint-Vis, S. Lebecque, J. Banchereau, and K. W. Moore. 1997. Follicular dendritic cells specifically express the long CR2/CD21 isoform. J. Exp. Med. 185: 165-170.
34. Cozine, C. L., K. L. Wolniak, and T. J. Waldschmidt. 2005. The primary germinal center response in mice. Curr. Opin. Immunol. 17: 298-302.
35. Timmer, T. C., B. Baltus, M. Vondenhoff, T. W. Huizinga, P. P. Tak, C. L. Verweij, R. E. Mebius, and T. C. van der Pouw Kraan. 2007. Inflammation and ectopic lymphoid structures in rheumatoid arthritis synovial tissues dissected by genomics technology: Identification of the interleukin-7 signaling pathway in tissues with lymphoid neogenesis. Arthritis Rheum. 56: 2492-2502.
36. Luther, S. A., T. Lopez, W. Bai, D. Hanahan, and J. G. Cyster. 2000. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-depen-dent lymphoid neogenesis. Immunity 12: 471-481.
37. Endres, R., M. B. Alimzhanov, T. Plitz, A. Futterer, M. H. Kosco-Vilbois, S. A. Nedospasov, K. Rajewsky, and K. Pfeffer. 1999. Mature follicular dendritic cell networks depend on expression of lymphotoxin β receptor by radioresistant stromal cells and of lymphotoxin β and tumor necrosis factor by B cells. J. Exp. Med. 189: 159-168.
38. Gommerman, J. L., and J. L. Browning. 2003. Lymphotoxin/light, lymphoid microenvironments and autoimmune disease. Nat. Rev. Immunol. 3: 642-655.
39. Seyler, T. M., Y. W. Park, S. Takemura, R. J. Bram, P. J. Kurtin, J. J. Goronzy, and C. M. Weyand. 2005. BLyS and APRIL in rheumatoid arthritis. J. Clin. Invest. 115: 3083-3092.
40. Vora, K. A., L. C. Wang, S. P. Rao, Z. Y. Liu, G. R. Majeau, A. H. Cutler, P. S. Hochman, M. L. Scott, and S. L. Kalled. 2003. Cutting edge: germinal centers formed in the absence of B cell-activating factor belonging to the TNF family exhibit impaired maturation and function. J. Immunol. 171: 547-551.
41. Yan, M., H. Wang, B. Chan, M. Roose-Girma, S. Erickson, T. Baker, D. Tumas, I. S. Grewal, and V. M. Dixit. 2001. Activation and accumulation of B cells in TACI-deficient mice. Nat. Immunol. 2: 638-643.
42. Seshasayee, D., P. Valdez, M. Yan, V. M. Dixit, D. Tumas, and I. S. Grewal. 2003. Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. Immunity 18: 279-288.
43. Armengol, M. P., M. Juan, A. Lucas-Martin, M. T. Fernandez-Figueras, D. Jaraquemada, T. Gallart, and R. Pujol-Borrell. 2001. Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers. Am. J. Pathol. 159: 861-873.
44. Salomonsson, S., P. Larsson, P. Tengner, E. Mellquist, P. Hjelmstrom, and M. Wahren-Herlenius. 2002. Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjogren's syndrome. Scand. J. Immunol. 55: 336-342.
45. Shi, K., K. Hayashida, M. Kaneko, J. Hashimoto, T. Tomita, P. E. Lipsky, H. Yoshikawa, and T. Ochi. 2001. Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients. J. Immunol. 166: 650-655.
46. Baeten, D., E. Kruithof, F. Van den Bosch, P. Demetter, N. Van Damme, C. Cuvelier, M. De Vos, H. Mielants, E. M. Veys, and F. De Keyser. 2001. Immunomodulatory effects of anti-tumor necrosis factor α therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study. Arthritis Rheum. 44: 186-195.
47. De Rycke, L., X. Verhelst, E. Kruithof, F. Van den Bosch, I. E. Hoffman, - E. M. Veys, and F. De Keyser. 2005. Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis. Ann. Rheum. Dis. 64: 299-302.
48. Thurlings, R. M., K. Vos, C. A. Wijbrandts, A. Zwinderman, D. M. Gerlag, and P. P. Tak. 2007. Synovial tissue response to Rituximab: mechanisms of action and identification of biomarkers of response. Ann. Rheum. Dis. 58: 61-72.
49. Fu, Y. X., and D. D. Chaplin. 1999. Development and maturation of secondary lymphoid tissues. Annu. Rev. Immunol. 17: 399-433.
50. Muller, G., U. E. Hopken, and M. Lipp. 2003. The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity. Immunol. Rev. 195: 117-135.
51. Muller, G., and M. Lipp. 2003. Concerted action of the chemokine and lymphotoxin system in secondary lymphoid-organ development. Curr. Opin. Immunol. 15:217-224.
52. Luther, S. A., A. Bidgol, D. C. Hargreaves, A. Schmidt, Y. Xu, J. Paniyadi, M. Matloubian, and J. G. Cyster. 2002. Differing activities of homeostatic che-mokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J. Immunol. 169: 424-433.
53. Browning, J. L., N. Allaire, A. Ngam-Ek, E. Notidis, J. Hunt, S. Perrin, and R. A. Fava. 2005. Lymphotoxin-β receptor signaling is required for the homeostatic control of HEV differentiation and function. Immunity 23: 539-550.
54. Page, G., and P. Miossec. 2004. Paired synovium and lymph nodes from rheumatoid arthritis patients differ in dendritic cell and chemokine expression. J. Pathol. 204: 28-38.
55. Thurlings, R. M., C. A. Wijbrandts, R. E. Mebius, T. Cantaert, H. Dinant, D. Baeten, and P. P. Tak. 2008. Synovial lymphoid neogenesis does not define a specific clinical rheumatoid arthritis subtype. Arthtitis Rheum. 58: 1582-1589.
56. + memory B cells. Immunity 26: 205-213.
57. + memory B cell development. J. Exp. Med. 203: 393-400.
58. Itoh, K., E. Meffre, E. Albesiano, A. Farber, D. Dines, P. Stein, S. E. Asnis, R. A. Furie, R. I. Jain, and N. Chiorazzi. 2000. Immunoglobulin heavy chain variable region gene replacement As a mechanism for receptor revision in rheumatoid arthritis synovial tissue B lymphocytes. J. Exp. Med. 192: 1151-1164.
59. Kim, H. J., V. Krenn, G. Steinhauser, and C. Berek. 1999. Plasma cell development in synovial germinal centers in patients with rheumatoid and reactive arthritis. J. Immunol. 162: 3053-3062.
60. +-AT-Pase-reactive TCR transgenic mouse. J. Immunol. 177: 7858-7867.
61. William, J., C. Euler, S. Christensen, and M. J. Shlomchik. 2002. Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science 297: 2066-2070.
62. William, J., C. Euler, N. Primarolo, and M. J. Shlomchik. 2006. B cell tolerance checkpoints that restrict pathways of antigen-driven differentiation. J. Immunol. 176: 2142-2152.
63. William, J., C. Euler, and M. J. Shlomchik. 2005. Short-lived plasmablasts dominate the early spontaneous rheumatoid factor response: differentiation pathways, hypermutating cell types, and affinity maturation outside the germinal center. J. Immunol. 174: 6879-6887.
64. Paul, E., J. Lutz, J. Erikson, and M. C. Carroll. 2004. Germinal center checkpoints in B cell tolerance in 3H9 transgenic mice. Int. Immunol. 16: 377-384.
65. Cappione, A., III, J. H. Anolik, A. Pugh-Bemard, J. Barnard, P. Dutcher, G. Silverman, and I. Sanz. 2005. Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J. Clin. Invest. 115: 3205-3216.
66. Bettclli, E., D. Baeten, A. Jager, R. A. Sobel, and V. K. Kuchroo. 2006. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J. Clin. Invest. 116: 2313-2316.
67. O'Neill, S. K., M. J. Shlomchik, T. T. Giant, Y. Cao, P. D. Doodes, and A. Finnegan. 2005. Antigen-specific B cells are required as APCs and autoanti-body-producing cells for induction of severe autoimmune arthritis. J. Immunol. 174: 3781-3788.